Security key
928661107
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)
CUSIP: 928661107
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 159,533,673
- Total 13F shares
- 16,142,878
- Share change
- -9,982,500
- Total reported value
- $4,127,281
- Price per share
- $0.26
- Number of holders
- 28
- Value change
- -$6,560,997
- Number of buys
- 15
- Number of sells
- 17
Report period
Q4 2025
Institutions
28
Top holders
10
VNRX full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
VOLITIONRX LTD SEC filings
VOLITIONRX LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 928661107
Recent filing periods:
Top shareholders of VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
5%
from 13D/G
|
9,380,425
|
$6,367,432 | — | 30 Sep 2025 | |
| Gaetan Michel |
3/4/5
|
Chief Operating Officer |
0.16%
|
256,746
|
$166,371 | — | 04 Oct 2025 | |
| Andrew Retter |
3/4/5
|
Chief Medical Officer |
0.09%
|
146,568
|
$63,610 | — | 01 Nov 2025 | |
| Lagoda Investment Management, L.P. |
13F
|
Company |
7.8%
|
12,487,000
|
$8,476,176 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.96%
|
1,530,048
|
$1,038,903 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.55%
|
878,170
|
$596,218 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.28%
|
445,187
|
$302,193 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.21%
|
329,520
|
$223,678 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.17%
|
268,638
|
$182,351 | — | 30 Sep 2025 | |
| Silverberg Bernstein Capital Management LLC |
13F
|
Company |
0.15%
|
232,082
|
$157,426 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
192,860
|
$130,913 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.05%
|
78,000
|
$52,946 | — | 30 Sep 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.04%
|
68,570
|
$46,545 | — | 30 Sep 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
40,733
|
$28,000 | — | 30 Sep 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
35,682
|
$24,221 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
30,596
|
$20,769 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
29,369
|
$19,936 | — | 30 Sep 2025 | |
| Cetera Investment Advisers |
13F
|
Company |
0.01%
|
20,050
|
$13,610 | — | 30 Sep 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
16,569
|
$11,000 | — | 30 Sep 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.01%
|
16,168
|
$6,867 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
14,827
|
$10,068 | — | 30 Sep 2025 | |
| Creative Planning |
13F
|
Company |
0.01%
|
10,056
|
$6,826 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
6,600
|
$4,000 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
4,408
|
$2,992 | — | 30 Sep 2025 | |
| Ameritas Advisory Services, LLC |
13F
|
Company |
0%
|
4,000
|
$2,715 | — | 30 Sep 2025 | |
| Founders Capital Management |
13F
|
Company |
0%
|
2,000
|
$1,358 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
960
|
$650 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
800
|
$543 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
700
|
$475 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
430
|
$292 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
348
|
$236 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
265
|
$180 | — | 30 Sep 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
200
|
$136 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
117
|
$79 | — | 30 Sep 2025 | |
| Eight Corp Ltd |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
24,030,664
mixed-class rows
|
$20,785,825 | — | 02 Jan 2024 | |
| Martin Charles Faulkes |
3/4/5
|
Executive Director, Director |
—
class O/S missing
|
2,096,207
|
$1,739,852 | — | 24 Jan 2024 | |
| Edward Futcher |
3/4/5
|
Director |
—
class O/S missing
|
436,436
|
$362,242 | — | 24 Jan 2024 | |
| Jason Bradley Terrell MD |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
33,192
|
$27,550 | — | 03 Aug 2022 | |
| Richard Brudnick |
3/4/5
|
Director |
—
class O/S missing
|
27,936
|
$23,187 | — | 12 Jan 2023 |
Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q4 2025
As of 31 Dec 2025,
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,142,878 shares.
The largest 10 holders included
Lagoda Investment Management, L.P., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., STATE STREET CORP, NORTHERN TRUST CORP, Silverberg Bernstein Capital Management LLC, CITADEL ADVISORS LLC, Squarepoint Ops LLC, and JANE STREET GROUP, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
32
Q4 2025 holders
28
Holder diff
-4
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.